ALK-Abelló A/S (OTCMKTS:AKBLF) Shares Down 2.6% – What’s Next?

ALK-Abelló A/S (OTCMKTS:AKBLF)’s stock price traded down 2.6% on Tuesday . The stock traded as low as $31.35 and last traded at $31.35. 105 shares changed hands during mid-day trading, a decline of 17% from the average session volume of 126 shares. The stock had previously closed at $32.1750.

ALK-Abelló A/S Stock Performance

The business’s 50 day simple moving average is $34.49 and its 200-day simple moving average is $33.78.

ALK-Abelló A/S Company Profile

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.